Skip to content
tranilast

Structure via PubChem · Public domain (PubChem)

EntityQ2325594· pop 7· linked from 9 articles

Also known as MK-341, SB-252218, MK 341, N-(3,4-Dimethoxycinnamoyl)anthranilic acid, tranilastum

Tranilast (INN, brand name Rizaben) is an antiallergic drug. It was developed by Kissei Pharmaceuticals and was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in the 1980s.

Chemical data

Formula
C18H17NO5
Molecular weight
327.3 g/mol
IUPAC name
2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid
SMILES
COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
InChIKey
NZHGWWWHIYHZNX-CSKARUKUSA-N
XLogP
3.2
Polar surface area
84.9 Ų
H-bond donors
2
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 3
Molecule type
Small molecule
Indications
rheumatoid arthritis, pterygium, scleredema adultorum, sarcoidosis

via ChEMBL · EBI

Research

840 papers

via PubMed

Wikidata facts

Mass
327.111
Has use
medication
Show 4 more facts
chemical formula
C₁₈H₁₇NO₅
canonical SMILES
COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC
isomeric SMILES
COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
World Health Organisation international non-proprietary name
tranilast
Sources (3)

via Wikidata · CC0

~4 min read

Encyclopedic overview

9 sections
Contents
  • Medical uses
  • Interactions
  • Adverse effects
  • Society and culture
  • Pharmacology
  • Chemistry
  • Research
  • History
  • References

{{Infobox drug | IUPAC_name = 2-{[(2E)-3-(3,4-Dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid | image = Tranilast.svg | image_class = skin-invert-image

| tradename = | Drugs.com = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = Not FDA approved | legal_status = Rx-only | routes_of_administration = Oral

Excerpted from Wikipedia’s “tranilast” article, available under the CC BY-SA 4.0 licence.

Available in 7 languages

via Wikidata sitelinks · CC0